Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102929 · ClinicalTrials.gov registry record · NA
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
A NA study of Schizophrenia, sponsored by Fabio Ferrarelli.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05102929 is a NA study of Schizophrenia that is actively recruiting participants, run by Fabio Ferrarelli. The registered enrollment target is 75 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05102929, a NA study of Schizophrenia, is actively recruiting participants, sponsored by Fabio Ferrarelli.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to evoke oscillatory activity, and EEG will record the responses of EC-SCZ participants. A working memory task will also be incorporated in order to determine how DLPFC natural frequency (NF) is related to working memory performance. iTBS (active or sham) will be administered, then the oscillatory activity of DLPFC and working memory performance will be reassessed. The overarching goal is to determine whether iTBS can acutely enhance the oscillatory activity of the DLPFC and to evaluate the relationship between changes in the DLPFC and working memory performance.
Conditions Studied
Interventions
- DEVICE active intermittent Theta Burst Stimulation (iTBS)
- DEVICE sham intermittent Theta Burst Stimulation (iTBS)
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-11-05 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05102929
The ClinicalTrials.gov registry entry for NCT05102929 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (66% lower). The listed sponsor is Fabio Ferrarelli, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which active intermittent Theta Burst Stimulation (iTBS) is the first listed.
NCT05102929 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05102929 about?
NCT05102929 is a clinical study titled "Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia". This study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to evoke oscillatory a...
What is the current status of trial NCT05102929?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2021-11-05. Estimated completion is 2026-08.
What conditions does trial NCT05102929 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT05102929?
The interventions under investigation include: active intermittent Theta Burst Stimulation (iTBS) (DEVICE), sham intermittent Theta Burst Stimulation (iTBS) (DEVICE).
Who is sponsoring clinical trial NCT05102929?
This trial is sponsored by Fabio Ferrarelli, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05102929 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
-
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.